Skip to main content
OpenTrials
Completed

NCT Number: NCT04614805

Timely Reperfusion in Acute ST-segment Myocardial Infarction

The aim of the study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Myocardial Infarction

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital North Norway

Tromsø, Troms Og Finnmark, 9038, Norway

About this study

In the regional health trust of North Norway, time to reperfusion in acute ST-elevation myocardial infarction is below the national average and below recommendations. The aim of this study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients. The study period is supposedly lasting for approximately 4 months, the time estimated to observe the clinical course of 100 patients. Before and during the study period, clinical leaders are encouraged to improve guideline adherence and to closely monitor the results of their own and collaborating institutions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient diagnosed with acute myocardial infarction with ST-elevations within our regional health trust during Nov 1st and for approx 4 months, and with an indication for reperfusion therapy (thrombolysis and/pr PCI)

Exclusion criteria

  • Reperfusion therapy not indicated or contraindicated

Treatment and study plan

Mobilizing clinical leaders

Behavioral

Clinical leaders and clinical personnel will regularly receive feedback regarding performance of their own hospital as well as other providers in the regional health trust of North Norway.

Primary outcomes

  1. Time to reperfusion

    Time frame: This parameter will be recorded within 1 week after patient inclusion

    Interval between 1st medical contact and opening of the infarction-related coronary artery.

Secondary outcomes

  1. Ejection fraction at discharge

    Time frame: This parameter will be recorded up to 6 months after patient inclusion

    Systolic function of the left ventricle

  2. Survival

    Time frame: This parameter will be collected from patient's records during Nov -20 till Aug -21.

    Survival after 30 days from incident

Sponsors and collaborators

Lead sponsor

University Hospital of North Norway

Other

Registry information

Official study title

Mobilizing Clinical Leadership to Achieve Timely Reperfusion in Acute ST-segment Elevation Myocardial Infarction

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Nov 4, 2020
Registry last updated
Jan 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.